John R. Stuelpnagel
Director · 10x Genomics, Inc.
IndividualSelling only
- 2025
- Sep 8, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John R. Stuelpnagel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Serge Saxonov - $6.82M in TXG purchases and sales in the last 12 months
- Adam Taich - $4.84M in TXG purchases and sales in the last 12 months
- Benjamin J. Hindson - $1.46M in TXG purchases and sales in the last 12 months
- Shehnaaz Suliman - $792K in TXG purchases and sales in the last 12 months
- Sarah A. Teichmann - $579K in TXG purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John R. Stuelpnagel?
John R. Stuelpnagel is a corporate insider, tracked as Director of 10x Genomics, Inc. (TXG). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John R. Stuelpnagel submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has John R. Stuelpnagel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($2.39M) across all tracked filings.
